Company Filing History:
Years Active: 1994
Title: A Glimpse into the Innovations of Shigeo Kitayama
Introduction: Shigeo Kitayama is a notable inventor based in Baltimore, MD, recognized for his significant contributions to the field of neuroscience through his patent related to the dopamine transporter protein. His work has implications for diagnostics and treatment in medical science, impacting both research and clinical applications.
Latest Patents: Kitayama holds a patent for "cDNA encoding a dopamine transporter." This invention encompasses a cloned cDNA that encodes the dopamine transporter protein commonly found in specific neural cells. The patent further details the purified dopamine transporter protein's application as a biosensor material and an immunogen for producing anti-DAT1 antibodies. It also presents methods for utilizing the cDNA in diagnostic and treatment settings and describes the use of permanent cell lines transformed with the dopamine transporter cDNA for pharmaceutical screening.
Career Highlights: Kitayama's esteemed career includes his work with the United States of America as represented by the Department of Health. His research influences both fundamental understanding and practical approaches to neurological conditions, paving the way for innovative therapeutic options.
Collaborations: Throughout his career, Kitayama has collaborated with esteemed professionals in the field, notably George R. Uhl and Michael J. Kuhar. These collaborations have enriched his research and expanded the potential applications of his innovations.
Conclusion: Shigeo Kitayama's pioneering work in encoding the dopamine transporter protein highlights his role as a significant inventor in the medical research domain. His patent reflects a dedication to advancing scientific knowledge and improving diagnostic and treatment methodologies in neuroscience. The impact of his contributions continues to resonate within the field, fostering future innovations.